Replies to post #467296 on *SCALPSWINGSTRADDLE* ($$$)

[THE_YAK]

...

[THE_YAK]

MDVN MDV3100 for prostate cancer positive shows positive survival data

Medivation and Astellas Pharma announced positive Independent Data Monitoring Committee results from a planned interim analysis of the Phase 3 AFFIRM trial of MDV3100 in men with advanced prostate cancer previously treated with chemotherapy. MDV3100 successfully met the study's pre-specified interim efficacy stopping criteria, demonstrating a clinically meaningful and statistically significant improvement in overall survival compared to placebo. MDV3100 produced a 4.8-month advantage in median overall survival compared to placebo. MDV3100 provided a 37 percent reduction in risk of death compared to placebo

[InvestorSuisse]

wow ill second that up 134% I almost thought it was a penny stock for a sec lol

[MercosurTrav]

Prostate cancer ... huge IMO, so does the market LOL!